1. "2017"
  2. "Gynecologic Medicine Service"
Formats
  1. Journal Article (61)
  2. Meeting Abstract (32)
Groups
  1. Department of Medicine (93)
  2. Gynecologic Medicine Service (93)
  3. Solid Tumor Oncology Division (93)
  4. Gynecology Disease Management Team (78)
  5. GDMT, Medicine (77)
  6. Survivorship Research (25)

More Groups

People
  1. Carol Aghajanian (27)
  2. David Hyman (15)
  3. Jason Konner (15)
  4. Martee Hensley (13)
  5. Robert Soslow (13)
  6. Vicky Makker (11)

More People

Years
  1. 2017 (93)
Publications
  1. Journal of Clinical Oncology (17)
  2. Gynecologic Oncology (16)
  3. Annals of Oncology (10)
  4. International Journal of Gynecological Cancer (5)
  5. Clinical Cancer Research (3)
  6. Modern Pathology (3)

More Publications

Publishers
  1. Elsevier Inc. (20)
  2. American Society of Clinical Oncology (19)
  3. Oxford University Press (11)
  4. American Association for Cancer Research (8)
  5. Lippincott Williams & Wilkins (7)
  6. Nature Publishing Group (5)

More Publishers

Results (93)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • OncoKB: A precision oncology knowledge base
    Journal Article

    Chakravarty, D.; Gao, J.; Phillips, S.; Kundra, R.; Zhang, H.; Wang, J.; Rudolph, J. E.; Yaeger, R.; Soumerai, T.; Nissan, M. H.; more...
    JCO Precision Oncology (2017)

    Fulltext@MSK | Save
  • Early clinical progression in patients with gynecologic malignancies receiving immunomodulatory antibody therapy
    Meeting Abstract

    Zamarin, D.; Martin, M.; Zecca, N.; Iasonos, A.; Zhou, Q.; Aghajanian, C.; Sabbatini, P.
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • The next generation of quality improvement at MSK: Turning chemotherapy process delays into chemo express
    Meeting Abstract

    Tota, J.; Levine, K.; Gordon, J.; Baldwin, A.; Wald, J.; Salvaggio, R.; Lee-Teh, M.; Freeswick, S.; O'Cearbhaill, R.; Reidy, D. L.
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Mirvetuximab soravtansine (IMGN853), a folate receptor alpha (FRĪ±)-targeting antibody-drug conjugate (ADC), in platinum-resistant epithelial ovarian cancer (EOC) patients (pts): Activity and safety analyses in phase I pooled expansion cohorts
    Meeting Abstract

    Moore, K. N.; Matulonis, U. A.; O'Malley, D. M.; Konner, J. A.; Martin, L. P.; Perez, R. P.; Bauer, T. M.; Gilbert, L.; Seward, S. M.; Oza, A. M.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • A phase Ib/II trial of lenvatinib (LEN) plus pembrolizumab (Pembro) in patients (Pts) with endometrial carcinoma
    Meeting Abstract

    Makker, V.; Rasco, D. W.; Dutcus, C. E.; Stepan, D. E.; Li, D.; Schmidt, E. V.; Shumaker, R. C.; Taylor, M. H.
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • A phase I dose-escalation study of intraperitoneal (IP) cisplatin, IV/IP paclitaxel, IV bevacizumab, and oral olaparib for newly diagnosed adenxal carcinoma
    Meeting Abstract

    Konner, J. A.; Boucicaut, N. N.; O'Cearbhaill, R. E.; Zamarin, D.; Makker, V.; Sabbatini, P.; Tew, W. P.; Cadoo, K. A.; Grisham, R. N.; Aghajanian, C.
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Phase II study of gemcitabine (G), trastuzumab (H), and pertuzumab (P) for HER2-positive metastatic breast cancer (MBC) after prior pertuzumab-based therapy
    Meeting Abstract

    Iyengar, N. M.; Smyth, L. M.; Lake, D.; Gucalp, A.; Singh, J. C.; Traina, T. A.; DeFusco, P. A.; Dickler, M. N.; Fornier, M. N.; Goldfarb, S. B.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Clinicopathologic characteristics of endometrial carcinoma metastatic to the ovary compared to endometrial carcinoma with synchronous ovarian carcinoma
    Meeting Abstract

    Rodriguez Gomez Hidalgo, N.; Soslow, R. A.; Weigelt, B.; Sioulas, V.; Aloisi, A.; Abu-Rustum, N.; Mueller, J. J.; Makker, V.; Leitao, M. M.
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • A phase II trial of enzalutamide in patients with androgen receptor positive (AR+) ovarian, primary peritoneal or fallopian tube cancer and one, two, or three prior therapies
    Meeting Abstract

    Grisham, R. N.; Giri, D. D.; Iasonos, A.; Zhou, Q.; Girshman, J.; McGrath, S. P.; O'Cearbhaill, R. E.; Sabbatini, P.; Tew, W. P.; Hyman, D. M.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Clinical benefit and toxicity of nivolumab plus ipilimumab in patients with advanced melanoma previously treated with checkpoint blockade inhibitors
    Meeting Abstract

    Friedman, C. F.; Wolchok, J. D.; Postow, M. A.; Shoushtari, A. N.; Callahan, M. K.; Momtaz, P.; Chapman, P. B.
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save